Patents Assigned to Alpha Therapy Solutions AB
  • Automatic process platform for the production of astatine-211 [At-211]-radiopharmaceuticals
    Patent number: 11851383
    Abstract: A system and method for automatic production of astatine-211 labeled molecules is described. The invention represents a significant advantage in the preparation of At-211 radiopharmaceuticals including better reproducibility, reduced production time and increased radiation safety. The invention also enables routine automatic synthesis of radiopharmaceuticals in a clinical setting, in conjunction or at short distance from a cyclotron unit capable of producing the radionuclide.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: December 26, 2023
    Assignee: Alpha Therapy Solutions AB
    Inventors: Sture Lindegren, Emma Aneheim
  • Automatic process platform for the production of astatine-211 [At 211] radiopharmaceuticals
    Patent number: 10829423
    Abstract: A system and method for automatic production of astatine-211 labeled molecules is described. The invention represents a significant advantage in the preparation of At-211 radiopharmaceuticals including better reproducibility, reduced production time and increased radiation safety. The invention also enables routine automatic synthesis of radiopharmaceuticals in a clinical setting, in conjunction or at short distance from a cyclotron unit capable of producing the radionuclide.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: November 10, 2020
    Assignee: Alpha Therapy Solutions AB
    Inventors: Sture Lindegren, Emma Aneheim